These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27507235)

  • 21. Libby: the long legacy of a public health disaster.
    van Dorn A
    Lancet Respir Med; 2017 Mar; 5(3):174-175. PubMed ID: 28215638
    [No Abstract]   [Full Text] [Related]  

  • 22. Conference summary. Directions and needs in asbestos research: new insights.
    Pfau JC; Pershouse M; Putnam EA
    Inhal Toxicol; 2006 Nov; 18(12):919-23. PubMed ID: 16920665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study.
    Sullivan PA
    Environ Health Perspect; 2007 Apr; 115(4):579-85. PubMed ID: 17450227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case series: rheumatological manifestations attributed to exposure to Libby Asbestiform Amphiboles.
    Diegel R; Black B; Pfau JC; McNew T; Noonan C; Flores R
    J Toxicol Environ Health A; 2018; 81(15):734-747. PubMed ID: 29927712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directions and needs in asbestos research: new insights: conference summary.
    Pfau JC; Pershouse M; Putnam EA
    J Immunotoxicol; 2008 Apr; 5(2):123-7. PubMed ID: 18569381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana.
    Vinikoor LC; Larson TC; Bateson TF; Birnbaum L
    Environ Health Perspect; 2010 Jul; 118(7):1033-28. PubMed ID: 20332072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nested case-control study of autoimmune disease in an asbestos-exposed population.
    Noonan CW; Pfau JC; Larson TC; Spence MR
    Environ Health Perspect; 2006 Aug; 114(8):1243-7. PubMed ID: 16882533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure pathway evaluations for sites that processed asbestos-contaminated vermiculite.
    Anderson BA; Dearwent SM; Durant JT; Dyken JJ; Freed JA; Moore SM; Wheeler JS
    Int J Hyg Environ Health; 2005; 208(1-2):55-65. PubMed ID: 15881979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer screening in patients with Libby amphibole disease: High yield despite predominantly environmental and household exposure.
    Loewen G; Black B; McNew T; Miller A
    Am J Ind Med; 2019 Dec; 62(12):1112-1116. PubMed ID: 31535393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases.
    Antao VC; Larson TC; Horton DK
    Curr Opin Pulm Med; 2012 Mar; 18(2):161-7. PubMed ID: 22139761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid progression of pleural disease due to exposure to Libby amphibole: "Not your grandfather's asbestos related disease".
    Black B; Szeinuk J; Whitehouse AC; Levin SM; Henschke CI; Yankelevitz DF; Flores RM
    Am J Ind Med; 2014 Nov; 57(11):1197-206. PubMed ID: 24898907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of scientific literature examining the mining history, geology, mineralogy, and amphibole asbestos health effects of the Rainy Creek igneous complex, Libby, Montana, USA.
    Bandli BR; Gunter ME
    Inhal Toxicol; 2006 Nov; 18(12):949-62. PubMed ID: 16920668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Select mortality and cancer incidence among residents in various U.S. communities that received asbestos-contaminated vermiculite ore from Libby, Montana.
    Horton DK; Bove F; Kapil V
    Inhal Toxicol; 2008 Jun; 20(8):767-75. PubMed ID: 18569099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence-The Pre-Adult Latency Study (PALS).
    Szeinuk J; Noonan CW; Henschke CI; Pfau J; Black B; Miller A; Yankelevitz DF; Liang M; Liu Y; Yip R; Linker L; McNew T; Flores RM
    Am J Ind Med; 2017 Jan; 60(1):20-34. PubMed ID: 27859510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure matrix development for the Libby cohort.
    Noonan CW
    Inhal Toxicol; 2006 Nov; 18(12):963-7. PubMed ID: 16920669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'We are the eyes and ears of researchers and community': Understanding the role of community advisory groups in representing researchers and communities in Malawi.
    Nyirenda D; Sariola S; Gooding K; Phiri M; Sambakunsi R; Moyo E; Bandawe C; Squire B; Desmond N
    Dev World Bioeth; 2018 Dec; 18(4):420-428. PubMed ID: 28872746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiographic abnormalities and asbestos exposure: Libby, Montana.
    Price B
    Environ Health Perspect; 2004 Feb; 112(2):A82-3, author reply A83. PubMed ID: 14754585
    [No Abstract]   [Full Text] [Related]  

  • 38. The Effects of Pleural Plaques on Longitudinal Lung Function in Vermiculite Miners of Libby, Montana.
    Clark KA; Flynn JJ; Karmaus WJJ; Mohr LC
    Am J Med Sci; 2017 Jun; 353(6):533-542. PubMed ID: 28641716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of autoantibody profiles in two asbestiform fiber exposure cohorts.
    Pfau JC; Barbour C; Black B; Serve KM; Fritzler MJ
    J Toxicol Environ Health A; 2018; 81(19):1015-1027. PubMed ID: 30230971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling community asbestos exposure near a vermiculite processing facility: Impact of human activities on cumulative exposure.
    Adgate JL; Cho SJ; Alexander BH; Ramachandran G; Raleigh KK; Johnson J; Messing RB; Williams AL; Kelly J; Pratt GC
    J Expo Sci Environ Epidemiol; 2011; 21(5):529-35. PubMed ID: 21343955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.